Wendy Johnson

Directeur Général chez Gemini Advisors

Profil

Wendy S.
Johnson founded Palkion, Inc. in 2008, where she worked as President and Aires Pharmaceuticals, Inc. in 2006, where she worked as President & Chief Executive Officer from 2006 to 2014.
Ms. Johnson also currently works at Gemini Advisors, as Managing Director, Accelerator Services Corp, as Operating Partner, Reneo Pharmaceuticals, Inc., as Chief Business Officer from 2021, and Formation Bio Inc, as Advisor.
Ms. Johnson also formerly worked at AmpliPhi Biosciences Corp., as Director from 2017 to 2019, US Food & Drug Administration, as Assistant Director-Devices & Radiological Health, Center for Devices & Radiological Health, as Assistant Director from 1976 to 1986, Exagen, Inc., as Independent Director from 2020 to 2024, Synbiotics LLC, as Manager-Business Development from 1988 to 1990, Women First HealthCare, Inc., as Vice President-Business Development from 1998 to 2000, ProQuest Management LLC, as Venture Partner from 2005 to 2014, Salmedix, Inc., as Senior Vice President-Corporate Development from 2001 to 2004, MorphoSys AG, as Member-Supervisory Board from 2015 to 2022, Prizm Pharmaceuticals, Inc., as Principal, Mutual of New York Life, as Vice President, Selective Genetics, Inc., as Vice President-Corporate Development & Operations from 1994 to 1998, Murex Corp., as Manager-International Business Development from 1988 to 1990, and Cytel Corp., as VP-Business Development & Regulatory Affairs from 1990 to 1994.
Ms. Johnson received her Masters Business Admin degree in 1986 from Loyola Marymount University, undergraduate degree in 1974 from the University of Maryland, and graduate degree from Drexel University College of Medicine.

Postes actifs de Wendy Johnson

Sociétés	Poste	Début
Gemini Advisors	Directeur Général	-
Trialspark, Inc.	Consultant / Advisor	-
Accelerator Services Corp	Private Equity Investor	-

Anciens postes connus de Wendy Johnson

Sociétés	Poste	Fin
EXAGEN INC.	Directeur/Membre du Conseil	10/06/2024
MORPHOSYS AG	Directeur/Membre du Conseil	18/05/2022
AmpliPhi Biosciences Corp.	Directeur des opérations	30/01/2017
ProQuest Management LLC	Private Equity Investor	30/03/2014
Aires Pharmaceuticals, Inc.	Directeur Général	01/03/2014